Search Results - "LUPI, Monica"

Refine Results
  1. 1

    Local Health Department Values and Organizational Authorities Guiding Cross-Sector Work During COVID-19 by Johnson, Karl, Biddell, Caitlin B., Gora Combs, Katherine, Wiesman, John, Valdes Lupi, Monica, Hassmiller Lich, Kristen

    Published in Health promotion practice (01-07-2024)
    “…Objective The COVID-19 pandemic highlighted the role that local health departments (LHDs) have in cross sector can address alone, including the work of value…”
    Get full text
    Journal Article
  2. 2

    DNA Damage Response Inhibitor Combinations Exert Synergistic Antitumor Activity in Aggressive B-Cell Lymphomas by Restelli, Valentina, Lupi, Monica, Chilà, Rosaria, Vagni, Micaela, Tarantelli, Chiara, Spriano, Filippo, Gaudio, Eugenio, Bertoni, Francesco, Damia, Giovanna, Carrassa, Laura

    Published in Molecular cancer therapeutics (01-07-2019)
    “…The DNA damage response (DDR) kinases ATR, Chk1, and Wee1 play vital roles in the response to replication stress and in maintaining cancer genomic stability…”
    Get full text
    Journal Article
  3. 3

    Combined inhibition of Chk1 and Wee1: In vitro synergistic effect translates to tumor growth inhibition in vivo by Carrassa, Laura, Chilà, Rosaria, Lupi, Monica, Ricci, Francesca, Celenza, Cinzia, Mazzoletti, Marco, Broggini, Massimo, Damia, Giovanna

    Published in Cell cycle (Georgetown, Tex.) (01-07-2012)
    “…Targeting Chk1 protein kinase can enhance the antitumor effects of radio- and chemotherapy. Recent evidence disclosed a role of Chk1 in unperturbed cell…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6
  7. 7

    In Vitro and In Vivo Activity of Lucitanib in FGFR1/2 Amplified or Mutated Cancer Models by Guffanti, Federica, Chilà, Rosaria, Bello, Ezia, Zucchetti, Massimo, Zangarini, Monique, Ceriani, Laura, Ferrari, Mariella, Lupi, Monica, Jacquet-Bescond, Anne, Burbridge, Mike F, Pierrat, Marie-Jeanne, Damia, Giovanna

    Published in Neoplasia (New York, N.Y.) (01-01-2017)
    “…Abstract The fibroblast growth factor receptor (FGFR) pathway has been implicated both as an escape mechanism from anti-angiogenic therapy and as a driver…”
    Get full text
    Journal Article
  8. 8

    Dynamic rendering of the heterogeneous cell response to anticancer treatments by Falcetta, Francesca, Lupi, Monica, Colombo, Valentina, Ubezio, Paolo

    Published in PLoS computational biology (01-10-2013)
    “…The antiproliferative response to anticancer treatment is the result of concurrent responses in all cell cycle phases, extending over several cell generations,…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13

    Glutaminase Inhibition on NSCLC Depends on Extracellular Alanine Exploitation by Caiola, Elisa, Colombo, Marika, Sestito, Giovanna, Lupi, Monica, Marabese, Mirko, Pastorelli, Roberta, Broggini, Massimo, Brunelli, Laura

    Published in Cells (Basel, Switzerland) (23-07-2020)
    “…Non-small-cell lung cancer (NSCLC) cell lines vary in their sensitivity to glutaminase inhibitors, so it is important to identify the metabolic assets…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Trypsinogen 4 boosts tumor endothelial cells migration through proteolysis of tissue factor pathway inhibitor-2 by Ghilardi, Carmen, Silini, Antonietta, Figini, Sara, Anastasia, Alessia, Lupi, Monica, Fruscio, Robert, Giavazzi, Raffaella, Bani, Maria Rosa

    Published in Oncotarget (29-09-2015)
    “…Proteases contribute to cancer in many ways, including tumor vascularization and metastasis, and their pharmacological inhibition is a potential anticancer…”
    Get full text
    Journal Article
  16. 16

    The molecular assembly of amyloid aβ controls its neurotoxicity and binding to cellular proteins by Manzoni, Claudia, Colombo, Laura, Bigini, Paolo, Diana, Valentina, Cagnotto, Alfredo, Messa, Massimo, Lupi, Monica, Bonetto, Valentina, Pignataro, Mauro, Airoldi, Cristina, Sironi, Erika, Williams, Alun, Salmona, Mario

    Published in PloS one (23-09-2011)
    “…Accumulation of β-sheet-rich peptide (Aβ) is strongly associated with Alzheimer's disease, characterized by reduction in synapse density, structural…”
    Get full text
    Journal Article
  17. 17

    Low levels of ALS-linked Cu/Zn superoxide dismutase increase the production of reactive oxygen species and cause mitochondrial damage and death in motor neuron-like cells by Rizzardini, Milena, Mangolini, Alessandra, Lupi, Monica, Ubezio, Paolo, Bendotti, Caterina, Cantoni, Lavinia

    Published in Journal of the neurological sciences (15-05-2005)
    “…Mutations of Cu/Zn superoxide dismutase (SOD1) are found in patients with familial amyotrophic lateral sclerosis (FALS). A cellular model of FALS was developed…”
    Get full text
    Journal Article
  18. 18

    The Contribution of p53 in the Dynamics of Cell Cycle Response to DNA Damage Interpreted by a Mathematical Model by Lupi, Monica, Matera, Giada, Natoli, Claudia, Colombo, Valentina, Ubezio, Paolo

    Published in Cell cycle (Georgetown, Tex.) (15-04-2007)
    “…Despite numerous studies on the tumor suppressor p53, a complete picture of its role in cell arrest and killing in G1, S and G2M phases after drug treatment is…”
    Get full text
    Journal Article
  19. 19

    Induction of miR-21 by Retinoic Acid in Estrogen Receptor-positive Breast Carcinoma Cells by Terao, Mineko, Fratelli, Maddalena, Kurosaki, Mami, Zanetti, Adriana, Guarnaccia, Valeria, Paroni, Gabriela, Tsykin, Anna, Lupi, Monica, Gianni, Maurizio, Goodall, Gregory J., Garattini, Enrico

    Published in The Journal of biological chemistry (01-02-2011)
    “…Retinoids are promising agents for the treatment/prevention of breast carcinoma. We examined the role of microRNAs in mediating the effects of…”
    Get full text
    Journal Article
  20. 20

    Interpreting cell cycle effects of drugs : the case of melphalan by LUPI, Monica, CAPPELLA, Paolo, MATERA, Giada, NATOLI, Claudia, UBEZIO, Paolo

    Published in Cancer chemotherapy and pharmacology (01-04-2006)
    “…Multiple effects usually occur in the cell cycle, during and after the exposure to a drug, while treated cells flowing through the cycle encounter G1, S and…”
    Get full text
    Journal Article